港股異動 | 康基醫療(09997.HK)放量反彈逾8% 回購+投行唱好
格隆匯11月24日丨日前創歷史新低的康基醫療(09997.HK)午後大幅拉昇反彈8.4%,報9.02港元,成交額放大至5487萬港元,總市值112.8億港元。進入四季度以來,公司持續進場回購。統計數據顯示,自10月5日至今,公司累計完成回購603萬股,耗資約5377萬港元。另外,高盛維持其“買入”評級,目標價15.5港元。集團管理層有信心今年收入達到增長30至40%的目標。該行上調對其2022至2023年銷售開支佔收入比例的預測,由7%上調至8至10%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.